About this trial
This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being diagnosed with Duchenne muscular dystrophy
To be literate in Turkish
To have scored 27 points or more on the Modified Mini Mental Test
Having a computer, tablet and internet connection
Disqualifiers
Having a neurological disease other than Duchenne muscular dystrophy and/or another diagnosed neurological disease accompanying Duchenne muscular dystrophy
Having a cooperation problem that prevents completing the assessments for any reason
Difficulty understanding and speaking the Turkish language
Trial design
Parallel
Treatments tested in this trial
Gamified occupational therapy programme
Other interventionGamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
Classic occupational therapy programme
Other interventionGamified occupational therapy program for the experimental group and classical occupational therapy program for the control group, which will be applied to both groups for eight weeks
Treatment groups
Trial outcomes
Primary outcomes
Demographic information form
Modified Mini Mental State Test
Vignos lower extremity functional scale
This scale was developed to assess the level of ambulation in neuromuscular diseases and consists of 10 stages. In this scale, the ambulation level of the person decreases from the first stage to the tenth stage.
Brooke upper extremity functional classification scale
This scale was developed to assess the functional levels of the upper extremity in neuromuscular diseases and consists of 6 stages. In this scale, progression from the first stage to the sixth stage indicates a decrease in the functionality of the upper extremity.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Başak Çağla Arslan
Lead sponsor
Lokman Hekim University
Sponsor institution
Hacettepe University
Collaborator